Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) announced that it will present results from six Kelun-led clinical studies at the 2025 American Society of Clinical Oncology (ASCO) Annual ...

CytoAgents Inc., a clinical-stage biotechnology company developing CTO1681 for the prevention and treatment for Cytokine Release Syndrome (CRS), announced the successful completion of the first dose, ...

Two former FDA leaders look at Commissioner Marty Makary’s early stumbles — and lay out a list of priorities to protect both ...

With its patented, AI-powered, FDA-certified transmission X-ray technology, since 2007 NanoRay Biotech is radically transforming medical and industrial X-ray applications in Taiwan and aims to further ...

Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...

With biotech firms caught in the crosshairs of Trump's tariffs, the levy could prove to be a boon for domestic producers but ...

The National Institutes of Health, an engine of American innovation in medical devices and biotechnology ... hopes of converting them into marketable products. Just generating a proof of concept ...

("Shineco" or the "Company"; NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, announced today that on April 22, 2025, its subsidiary, Shineco Life ...

The development of medical technologies such as medical devices, pharmaceuticals, biotechnology products, and diagnostic tools has increased the need for more stringent testing and certification ...

The FDA has not responded to Fierce Biotech’s request for comment ... She led initiatives that support making effective and safe medical products available to Americans by ensuring timely ...

The role of insects in drug discovery is expanding, with biopharmaceuticals derived from insect cells offering sustainable ...